Rubidium: social and political problems

What problems does it cause between people, and who carries them?

We found no war, smuggling or trade dispute about rubidium. The main problem we found was medical. In 2011 the US regulator told health care workers to stop using a rubidium-82 generator after two patients received more radiation than expected. In 2012 it announced its return.

Last updated 10 October 2026.

Conflict and disputes

We found no armed conflict, smuggling or trade dispute that is about rubidium.

Workers and communities

Rubidium comes from a few pegmatite mines that also give cesium and lithium. In 2015 a collapse at the Tanco mine in Canada ended pollucite mining there1. We found no report of injuries in that collapse, and no report of harm to workers or local people that is specific to rubidium.

Who gains and who loses

No one publishes the value of a year’s rubidium (see Market).

In 2011 two patients received more radiation than expected from heart scans with rubidium-82. Radioactive strontium from the generator had passed into the dose2. The US Food and Drug Administration (FDA) told health care workers to stop using the generator, and the maker, Bracco, recalled it2. The FDA said that it believed the risk of harm was minimal2.

In a later survey by Bracco, 54 of 375 patients needed more radiation tests. All 54 were from two clinical sites3. The FDA concluded that improper use at some sites was the likely cause, not faulty generators4. In February 2012 the FDA announced that the generator would return to the market, with a new boxed warning. Sites must do extra daily tests when strontium levels reach alert limits4. The boxed warning is still on the 2026 label5.

Sources

  1. 1

    U.S. Geological Survey (Candice C. Tuck), 2021. Rubidium, in Mineral Commodity Summaries 2021 .

    The Tanco mine collapse of 2015, the German refinery, the Karibib project.

    • the Tanco Mine in Canada shutting down and later being sold after a mine collapse in 2015
  2. 2

    Diagnostic Imaging (Todd Neff), 2011. FDA Halts CardioGen-82, Bracco Starts Recall .

    The FDA warning and recall of July 2011 after strontium breakthrough.

    • two patients who received more radiation than expected from CardioGen-82 due to a … strontium breakthrough
    • Health care professionals should stop using CardioGen-82 for cardiac positron emission tomography (PET) scans, the FDA said. The manufacturer, Bracco Diagnostics Inc. is voluntarily recalling CardioGen-82
    • The FDA says it believes that the risk of harm is minimal
  3. 3

    Diagnostic Imaging (Todd Neff), 2012. FDA: Bracco CardioGen 'Strontium Breakthrough' Caused by User Error .

    The survey of 375 patients and the FDA finding of January 2012.

    • of 375 patients surveyed at 43 clinical sites, 54 patients were planned for further radiation testing because of abnormal screening test results. All 54 patients were from two clinical sites.
  4. 4

    Medscape (Michael O'Riordan), 2012. CardioGen-82 Returns to Market .

    The return of the generator in February 2012 and the FDA conclusion on the cause.

    • of the generator at certain sites likely caused the radiation exposure to patients and was not the result of faulty devices
    • will be returning to market … includes a new boxed warning … if the levels reach these alert limits, additional daily eluate testing is performed
  5. 5

    Bracco Diagnostics Inc. (label approved by the U.S. Food and Drug Administration), 2026. CardioGen-82 (rubidium Rb 82 generator), full prescribing information .

    First US approval in 1989, the boxed warning on radiation from strontium, half-lives of rubidium-82 and strontium-82.

    • WARNING: HIGH LEVEL RADIATION EXPOSURE WITH USE OF INCORRECT ELUENT and